Big Tech stocks are treading water after $1 trillion sell-off week

Big Tech stocks are treading water after  trillion sell-off week


Big Tech stocks were treading water in premarket trading on Monday, after a bruising week that saw more than $1 trillion wiped from their market caps.

As of 6:40 a.m. ET, Oracle was up 1.6% and Microsoft had edged 0.8% higher. Meta was down 0.2% and Amazon was flat. Alphabet fell 0.5% and Nvidia was down around 0.9% after rebounding 7.9% on Friday.

The market grew jittery after expenditure outlooks continued to shoot through the roof in Big Tech earnings last week, as companies doubled down on AI bets.

Amazon, Alphabet, Microsoft and Meta reported a combined capital expenditure of about $120 billion in the fourth quarter alone. The figure could approach $700 billion in 2026, higher than the gross domestic product of countries like the United Arab Emirates, Singapore and Israel.

Jim Reid, head of global macro research at Deutsche Bank, wrote in a Monday note that last week was the worst for the “Magnificent 7” stocks since April, when U.S. tariffs plunged markets into crisis and the stocks fell 4.66%.

Nvidia CEO Jensen Huang: AI is going to fundamentally change how we compute everything

Signs of recovery were on show as the markets closed last week, with Magnificent 7 stocks rising 0.45% on Friday, despite Amazon falling 5.55%, Reid said.

Cloud companies’ growing margins come alongside “potential stock volatility” amid macro headwinds, said Justin Post, a research analyst at Bank of America Securities, in a note on Monday.

“But management teams seem confident in their ability to forecast demand and that capacity will be fully utilized in 2026,” he added.

The markets reacted negatively to Amazon and Alphabet’s capex guidance being “well above” consensus expectations, said David Lefkowitz, CIO head of US equities at UBS Financial Services on Friday, adding this “overshadowed stronger-than-expected cloud growth for both companies.”

Nvidia CEO Jensen Huang told CNBC’s “Halftime Report” on Friday that the tech industry’s surging capital expenditures for AI infrastructure were justified, given the “sky high” demand for computing power.

Analysts predict room to grow for hyperscaler capex.

“As monthly tokens processed grows exponentially, aggregate cloud revenue for GCP/AWS/Azure accelerates, data center commitments expand, and data center component suppliers highlight accelerating demand, we believe there will continue to be upward pressure on hyperscaler capex estimates,” Morgan Stanley said in a note on Monday morning.



Source

Howard Marks says there are very few cheap stocks: ‘Bargains come when people panic’
World

Howard Marks says there are very few cheap stocks: ‘Bargains come when people panic’

Howard Marks warned that investors hunting for bargains may be disappointed, saying markets are still far from distressed levels despite bouts of volatility. The co-founder and co-chairman of Oaktree Capital Management, who famously foresaw the dot-com bubble, said the current environment reflects an ongoing “tug of war” between bullish and bearish forces, with optimism largely […]

Read More
Investors are misreading news about the Iran war, analysts say as markets whipsaw
World

Investors are misreading news about the Iran war, analysts say as markets whipsaw

An Iranian flag flutters as a woman walks past damaged buildings amid a 10-day ceasefire between Lebanon and Israel, in the southern suburbs of Beirut, Lebanon, April 20, 2026. Marko Djurica | Reuters “Complacent” investors risk getting wrong-footed as they continue to misread developments in the Iran war, analysts said after markets reacted to the […]

Read More
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to  billion
World

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company said Monday. Lilly will pay $3.25 billion upfront, and the remaining payments are contingent upon clinical, […]

Read More